Você procurou por: doksorubicinom (Esloveno - Inglês)

docetaksel v kombinaciji z doksorubicinom
docetaxel in combination with doxorubicin

kombinaciji z doksorubicinom in ciklofosfamidom.
administered in combination with doxorubicin and cyclophosphamide.

26 taxotere v kombinaciji z doksorubicinom
26 taxotere in combination with doxorubicin

zdravilo taxotere v kombinaciji z doksorubicinom
taxotere in combination with doxorubicin

63 docetaxel winthrop v kombinaciji z doksorubicinom
62 docetaxel winthrop in combination with doxorubicin

kombinaciji z doksorubicinom ali trastuzumabom ali kapecitabinom.
or in combination with doxorubicin, or trastuzumab, or capecitabine.

docetaksel 75 mg/m2 v kombinaciji z doksorubicinom
docetaxel 75 mg/m² in combination with cisplatin:

49 taxotere 75 mg/ m2 v kombinaciji z doksorubicinom
50 taxotere 75 mg/ m² in combination with doxorubicin

13 docetaxel winthrop 75 mg/ m2 v kombinaciji z doksorubicinom
13 docetaxel winthrop 75 mg/ m² in combination with doxorubicin

54 taxotere 75 mg/ m2 v kombinaciji z doksorubicinom in ciklofosfamidom
55 taxotere 75 mg/ m² in combination with doxorubicin and cyclophosphamide

258 bolnikih, ki so dobivali docetaksel v kombinaciji z doksorubicinom;
258 patients who received docetaxel in combination with doxorubicin.

toksičnost v kombinaciji z doksorubicinom je bila aditivna, ne pa sinergistična.
the toxicity in combination with doxorubicin was additive and not synergistic.

18 docetaxel winthrop 75 mg/ m2 v kombinaciji z doksorubicinom in ciklofosfamidom
18 docetaxel winthrop 75 mg/ m² in combination with doxorubicin and cyclophosphamide

zdravilo docetaksel teva v kombinaciji z doksorubicinom in ciklofosfamidom: adjuvantno zdravljenje
docetaxel in combination with doxorubicin and cyclophosphamide: adjuvant therapy

zdravilo docetaxel winthrop v kombinaciji z doksorubicinom in ciklofosfamidom: adjuvantno zdravljenje
docetaxel winthrop in combination with doxorubicin and cyclophosphamide: adjuvant therapy

po adjuvantni kemoterapiji z doksorubicinom in ciklofosfamidom, v kombinaciji s paklitakselom ali docetakselom;
following adjuvant chemotherapy with doxorubicin and cyclophosphamide, in combination with paclitaxel or docetaxel.

o medsebojnem delovanju z doksorubicinom so poročali tudi pri streptozocinu, fenobarbitalu, fenitoinu in varfarinu.
interactions with doxorubicin have also been reported for streptozocin, phenobarbital, phenytoin and warfarin.

zdravilo docetaksel accord je v kombinaciji z doksorubicinom in ciklofosfamidom indicirano za adjuvantno zdravljenje bolnic:
docetaxel accord in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:

bortezomib v kombinaciji s pegiliranim liposomskim doksorubicinom (študija doxil-mmy-3001)
bortezomib combination treatment with pegylated liposomal doxorubicin (study doxil-mmy-3001)

pri bolnikih, ki prejemajo olaratumab v kombinaciji z doksorubicinom, se je treba izogibati cepljenju z živim cepivom.
vaccination with a live vaccine should be avoided in patients receiving olaratumab in combination with doxorubicin.